arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Genmab A/S

GMAB Health Care Biotechnology: Pharmaceutical Preparations
$28.85
Today
as of Jul 22, 16:49 ET
Last 30 days +15.03% Jun 12 → Jul 22
$24.16 $25.67 $27.18 $28.69 $30.20 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$24.73
High
$25.29
Low
$24.69
Volume
$2M
Avg Vol
$2M
Mkt Cap
$3.6B
P/E (TTM)
—
Beta
—
52w High
$35.43
52w Low
$20.23
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 16 items

Jul 22 · 11:25 MT Newswires
TD Cowen Upgrades Genmab to Buy From Hold, Raises Price Target to $43 From $32
Jul 15 · 11:20 MT Newswires
Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales
Jul 15 · 10:22 PR GlobeNewswire
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
▸ Show all 16 press releases & news Free account →

Overview

52-week range
$20
$35
57% of range
Avg surprise (last 3)
+24.4%
Avg reaction (last 2)
-4.4%
0% positive
Latest IV / EM
65%
EM ±14.8% · $30 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.15$0.25$0.34$0.44$0.54 Actual $0.31Est $0.23Actual $0.54Est $0.39Actual $0.15Est $0.15 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $0.15 $0.15 0.0% -51.6% -3.0% earnings
Thu Aug 7, 2025Jun/2025 $0.54 $0.39 +38.5% — — earnings
Thu May 8, 2025Mar/2025 $0.31 $0.23 +34.8% — -5.7% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 6, 2026Jun/2026BMO $0.35$0.54 -35.2%

Implied volatility — last 90 days

45%97%149%201%253% Jun 07 — IV 53% · EM ±7.4%Jun 11 — IV 50% · EM ±5.5%Jun 12 — IV 57% · EM ±5.8%Jun 16 — IV 253% · EM ±15.0%Jun 19 — IV 91% · EM ±20.2%Jun 22 — IV 58% · EM ±12.1%Jun 23 — IV 94% · EM ±19.3%Jun 24 — IV 67% · EM ±13.4%Jun 25 — IV 73% · EM ±14.3%Jun 26 — IV 100% · EM ±19.1%Jun 29 — IV 101% · EM ±17.9%Jun 30 — IV 119% · EM ±20.6%Jul 01 — IV 121% · EM ±20.3%Jul 02 — IV 96% · EM ±15.6%Jul 03 — IV 100% · EM ±15.6%Jul 06 — IV 115% · EM ±15.9%Jul 07 — IV 72% · EM ±9.5%Jul 08 — IV 46% · EM ±5.8%Jul 14 — IV 65% · EM ±4.7%Jul 20 — IV 72% · EM ±17.1%Jul 21 — IV 89% · EM ±20.6%Jul 22 — IV 65% · EM ±14.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in